TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
OCS

Oculis Holding AG

Healthcare · Biotechnology

9.10$ -2.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow OCS
Line item 2020 2021 2022 2023 2024 2025
– – – – – –
– +3.1% +27.2% -4.0% +41.5% +34.5%
– +0.0% +145.1% +348.8% +171.1% +64.0%
– +72.3% – – – –
– – – -316.6% – -100.5%
– +47.4% +12,571.4% -98.6% +379.2% +25.0%
– +47.4% +12,571.4% +1,427.9% -67.6% +238.2%
– – – – – –
– +62.2% +0.0% -0.6% +73.4% +36.1%
– +1,035.9% -96.9% +7,465.5% -58.3% +230.6%
– – -164.1% – -157.3% –
– – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?